Free Trial

Boston Partners Sells 3,311 Shares of Procter & Gamble Company (The) (NYSE:PG)

Procter & Gamble logo with Consumer Staples background

Key Points

  • Boston Partners decreased its holdings in Procter & Gamble by 1.0%, totaling 341,489 shares worth approximately $58.2 million, after selling 3,311 shares in the first quarter.
  • Procter & Gamble's earnings report showed an EPS of $1.48, surpassing analysts' expectations and reflecting a revenue growth of 1.7% year-over-year, with revenue reaching $20.89 billion.
  • The company announced a quarterly dividend of $1.0568 per share, which translates to an annualized payout of $4.23 and a yield of 2.7% as of the recent financial disclosures.
  • Looking to export and analyze Procter & Gamble data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Boston Partners reduced its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 1.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 341,489 shares of the company's stock after selling 3,311 shares during the quarter. Boston Partners' holdings in Procter & Gamble were worth $58,197,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in PG. Nuveen LLC bought a new position in shares of Procter & Gamble in the first quarter valued at approximately $1,954,941,000. GAMMA Investing LLC grew its stake in shares of Procter & Gamble by 20,758.5% during the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock worth $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Capital Research Global Investors raised its position in shares of Procter & Gamble by 62.5% in the 4th quarter. Capital Research Global Investors now owns 7,398,120 shares of the company's stock valued at $1,240,294,000 after acquiring an additional 2,846,560 shares during the period. Northern Trust Corp grew its holdings in shares of Procter & Gamble by 10.1% in the 4th quarter. Northern Trust Corp now owns 29,395,208 shares of the company's stock valued at $4,928,107,000 after buying an additional 2,703,757 shares during the period. Finally, Invesco Ltd. increased its stake in Procter & Gamble by 19.8% during the 1st quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock worth $2,299,580,000 after purchasing an additional 2,228,151 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

PG has been the topic of several research reports. Barclays set a $164.00 target price on Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Wells Fargo & Company dropped their price target on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Piper Sandler lifted their target price on Procter & Gamble from $160.00 to $164.00 and gave the company a "neutral" rating in a research report on Monday, May 5th. JPMorgan Chase & Co. reiterated a "neutral" rating and issued a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the stock a "buy" rating in a report on Wednesday, July 30th. Seven investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat, Procter & Gamble currently has an average rating of "Moderate Buy" and an average target price of $175.94.

Get Our Latest Analysis on PG

Procter & Gamble Stock Up 0.4%

Shares of PG traded up $0.56 during trading hours on Friday, reaching $154.30. 7,120,993 shares of the stock traded hands, compared to its average volume of 7,395,259. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The company has a market cap of $361.43 billion, a price-to-earnings ratio of 23.70, a PEG ratio of 4.07 and a beta of 0.37. The stock has a fifty day simple moving average of $157.19 and a 200 day simple moving average of $163.24. Procter & Gamble Company has a 52 week low of $149.91 and a 52 week high of $180.43.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same quarter last year, the business posted $1.40 EPS. Procter & Gamble's quarterly revenue was up 1.7% compared to the same quarter last year. On average, equities analysts forecast that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were issued a dividend of $1.0568 per share. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. The ex-dividend date of this dividend was Friday, July 18th. Procter & Gamble's dividend payout ratio is 64.98%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines